[Federal Register Volume 59, Number 183 (Thursday, September 22, 1994)]
[Unknown Section]
[Page 0]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-23375]
[[Page Unknown]]
[Federal Register: September 22, 1994]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Request for Nominations for Members on Public Advisory
Committees; Science Advisory Board to the National Center for
Toxicological Research
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is requesting
nominations for members to serve on the Science Advisory Board (the
board) to the National Center for Toxicological Research. Three
vacancies will occur on June 30, 1995.
FDA has a special interest in ensuring that women, minority groups,
and individuals with disabilities are adequately represented on
advisory committees and, therefore, extends particular encouragement to
nominations for appropriately qualified female, minority, and
physically disabled candidates. Final selections from among qualified
candidates for each vacancy will be determined by the expertise
required to meet specific agency needs and in a manner to ensure
appropriate balance of membership.
DATES: Nominations should be received by October 24, 1994.
ADDRESSES: All nominations for membership, except for general public
representatives (consumer-nominated members), should be sent to Barbara
J. Jewell (address below). All nominations for general public
representatives (consumer-nominated members) should be sent to Susan K.
Meadows (address below).
FOR FURTHER INFORMATION CONTACT:
Regarding all nominations for membership, except for general public
representatives (consumer-nominated members): Barbara J. Jewell,
National Center for Toxicological Research (HFT-10), Food and Drug
Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-443-3155.
Regarding all nominations for general public representatives
(consumer-nominated members): Susan K. Meadows, Office of Consumer
Affairs (HFE-40), Food and Drug Administration, 5600 Fishers Lane,
Rockville, MD 20857, 301-443-5006.
SUPPLEMENTARY INFORMATION: FDA is requesting nominations for members to
serve on the board to the National Center for Toxicological Research
(NCTR). The function of the board is to advise the Director, NCTR, on
establishment and implementation of a research program that will assist
in fulfilling the regulatory responsibilities of the Commissioner of
Food and Drugs. The board provides an extra-agency review to ensure
that the research programs at NCTR are scientifically sound and
pertinent.
Criteria for Members
Persons nominated for membership shall have adequately diversified
experience that is appropriate to the work of the board in the fields
related to toxicological research.
The specialized training and experience necessary to qualify
nominees as experts suitable forappointment are subject to review, but
may include experiencein medical practice, teaching, and/or research
relevant to the field of activity of the board. The term of office is
up to 4 years, depending on the appointment date.
General Public Representatives (Consumer-nominated Members)
FDA currently attempts to place on committees members who are
nominated by consumer organizations. These members are recommended by a
consortium of 12 consumer organizations that has the responsibility for
screening, interviewing, and recommending consumer-nominated candidates
with appropriate scientific credentials. Candidates are sought who are
aware of the consumer impact of committee issues, but who also possess
enough technical background to understand and contribute to the
committee's work. For some advisory committees the agency notes,
however, it may require such nominees to meet the same technical
qualifications and specialized training required of other expert
members of the committee. The term of office for these members is up to
4 years, depending on the appointment date. Nominations are invited for
consideration for membership as openings become available.
Nomination Procedures
Any interested person may nominate one or more qualified persons
for membership on the board. Nominations shall state that the nominee
is aware of the nomination, is willing to serve as a member of the
board, and appears to have no conflict of interest that would preclude
board membership. Potential candidates will be asked by FDA to provide
detailed information concerning such matters as financial holdings,
consultancies, and research grants or contracts in order to permit
evaluation of possible sources of conflict of interest.
This notice is issued under the Federal Advisory Committee Act (5
U.S.C. app. 2) and 21 CFR part 14, relating to advisory committees.
Dated: September 15, 1994.
Linda A. Suydam,
Interim Deputy Commissioner for Operations.
[FR Doc. 94-23375 Filed 9-22-94; 8:45 am]
BILLING CODE 4160-01-F
